Core Laboratories Joint Venture Agreement
VIBGYOR Scientific Research, genae associates, Cardiovascular Center Aalst and J.B. Dahm, MD have reached an agreement to form a Core Laboratories joint venture, called imaeon.
Core Laboratories joint venture agreement between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm
6 October 2008 - Antwerp, Ahmedabad, Aalst, Göttingen
VIBGYOR Scientific Research, genae associates, Cardiovascular Center Aalst and J.B. Dahm, MD have reached an agreement to form a Core Laboratories joint venture, called imaeon.
imaeon initially will focus on the performance of medical images analysis for clinical research projects, including but not limited to: quantitative coronary and peripheral angiography (QCA, QVA), computed tomography (CT) angiography, intravascular ultrasound (IVUS) and IVUS related
techniques, multiple gated acquisition scan (MUGA), optical coherence tomography (OCT), magnetic resonance imaging (MRI), multi slice computer tomography (MSCT), electrocardiogram (ECG) and ECHO assessments.
While meeting or exceeding all quality standards in a timely and cost-effective manner, imaeon will offer expert evaluations of medical images from multi-modality environments and unsurpassed quality clinical research services. It will operate from the main facilities and offices in Ahmedabad,
India and from the subsidiary in Antwerp, Belgium and focus on the pharmaceutical, biomedical and medical device industries.
About Cardiovasculair Onderzoek Aalst CVBA
Cardiovasculair Onderzoek Aalst, with principal offices in Aalst, Belgium, provides consultancy assignments and logistics support related to scientific research and scientific studies for physicians, hospitals, universities, pharmaceutical institutions, governments and governmental institutions.
Contact
Paul Nellens, MD - paul.nellens@olvz-aalst.be
About genae associates nv
genae is a privately held NV/SA with principal offices in Antwerp, Belgium and is ISO 9001:2000 certified for CRO, Core Laboratories and Services Provider for the Medical Industries. These global services include but are not limited to Clinical Data Management, Electronic Data Capture
(EDC), Statistical Analysis, Scientific & Medical Writing, CE-Marking (MDD) and Training & Education.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
